Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

F. Hoffmann-La Roche Ltd

Novartis AG

Pfizer Inc

Sanofi

Celgene Corp

AstraZeneca Plc

Eli Lilly and Company

Merck & Co Inc

Otsuka Holdings Co Ltd ...

F. Hoffmann-La Roche Ltd

Novartis AG

Pfizer Inc

Sanofi

Celgene Corp

AstraZeneca Plc

Eli Lilly and Company

Merck & Co Inc

Otsuka Holdings Co Ltd

AbbVie Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment ...

Table of Contents 2

List of Tables 4

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12

Top Five Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials 27

Prominent Drugs 28

Latest Clinical Trials News on Pancreatic Cancer 29

Feb 02, 2017: Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients 29

Jan 27, 2017: Redx outlines growing opportunity for Porcupine inhibitors 29

Jan 20, 2017: ARMO BioSciences Presents New Phase 1b Clinical Data for AM0010 in Advanced Pancreatic Cancer Patients at 2017 Gastrointestinal Cancers Symposium 29

Jan 20, 2017: Pamrevlumab Pancreatic Cancer Clinical Data Presented at ASCO 2017 Gastrointestinal Cancers Symposium 30

Jan 20, 2017: ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor CCX872 in Patients with Advanced Non-Resectable Pancreatic Cancer 31

Jan 17, 2017: BioLineRx Announces Initiation of Immuno-Oncology Phase 2 Study to Investigate Combination of BL-8040 and KEYTRUDA for Pancreatic Cancer 31

Jan 11, 2017: Celyad Announces Registration of the First Pancreatic Cancer Patient in its CAR-T NKR-2THINK Trial in Belgium 32

Jan 05, 2017: Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints 32

Dec 23, 2016: Anti-AXL Biologic Increases Tumor Sensitivity to Radiation and Check-Point Inhibitors 33

Dec 22, 2016: Propanc Commences GLP-Compliant 28-Day Repeat-Dose Toxicity Study 33

Dec 12, 2016: PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial 34

Dec 07, 2016: PharmaCyte Biotech Discusses Upcoming Clinical Trial in Pancreatic Cancer with First Principal Investigator 35

Dec 07, 2016: Sun BioPharma to Initiate Fifth Patient Cohort in its Dose Escalation Phase 1 Study of SBP-101 for Pancreatic Cancer 35

Dec 05, 2016: MabVax Therapeutics Expands Phase I Clinical Trial Investigation for Patients with Pancreatic Cancer to Include HonorHealth Research Institute 36

Dec 01, 2016: VAXIMM Presents Preclinical Data on VXM01 at EORTC-NCI-AACR Symposium 36

Dec 01, 2016: VAXIMM Presents Preclinical Data on VXM-04 at EORTC-NCI-AACR Symposium 37

Dec 01, 2016: PharmaCyte Biotech Moves Closer to Enrolling Patients in Pancreatic Cancer Clinical Trial 37

Nov 30, 2016: Promising results from new drug combination in patients with advanced solid tumors 39

Nov 30, 2016: Pre-clinical profile of Porcupine inhibitor RXC004 presented at EORTC-NCI-AACR 2016 39

Nov 29, 2016: New Research Validates both Single Agent and Synergistic Anticancer Activity for Aravive Biologics’ Anti-AXL Candidate in Multiple Tumor Types 40

Nov 28, 2016: MabVax Therapeutics Enrolls First Patients in Expansion of Phase I Clinical Trial Treating Newly Diagnosed Pancreatic Cancer Patients 40

Nov 14, 2016: Provectus Biopharmaceuticals Announces Poster Presentation on PV-10 at Society for Immunotherapy of Cancer 2016 Annual Meeting 41

Nov 14, 2016: VCN Biosciences to present clinical data on systemic administration of VCN- 01 in pancreatic cancer patients at 28th EORTC-NCI-AACR SYMPOSIUM on Molecular Targets & Cancer Therapeutics 41

Clinical Trial Profile Snapshots 42

Appendix 1603

Abbreviations 1603

Definitions 1603

Research Methodology 1605

Secondary Research 1606

About GlobalData 1607

Contact Us 1607

Disclaimer 1607

Source 1608

List of tables

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 6

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Pancreatic ...

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 6

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8

Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9

Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10

Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 11

Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12

Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 13

Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 14

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16

Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 17

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 20

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22

Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23

Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24

Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25

Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26

Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27

Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of figures

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 6

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Pancreatic ...

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 6

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8

Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9

Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10

Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11

Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12

Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 13

Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 14

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16

Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 17

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22

Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23

Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24

Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25

Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26

Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27

Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

GlobalData Methodology 1605

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports